Amicus Therapeutics, Inc. (FRA:AM6)

Amicus Therapeutics Statistics

Total Valuation

FRA:AM6 has a market cap or net worth of EUR 3.82 billion. The enterprise value is 3.95 billion.

Market Cap	3.82B
Enterprise Value	3.95B

Important Dates

The last earnings date was Wednesday, February 18, 2026.

Earnings Date	Feb 18, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	314.00M
Shares Outstanding	n/a
Shares Change (YoY)	+1.31%
Shares Change (QoQ)	-0.45%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	311.33M

Valuation Ratios

PE Ratio	n/a
Forward PE	22.41
PS Ratio	7.08
PB Ratio	16.36
P/TBV Ratio	71.77
P/FCF Ratio	150.34
P/OCF Ratio	135.39
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 91.84, with an EV/FCF ratio of 155.31.

EV / Earnings	-171.00
EV / Sales	7.33
EV / EBITDA	91.84
EV / EBIT	134.86
EV / FCF	155.31

Financial Position

The company has a current ratio of 2.84, with a Debt / Equity ratio of 1.61.

Current Ratio	2.84
Quick Ratio	1.72
Debt / Equity	1.61
Debt / EBITDA	8.73
Debt / FCF	14.82
Interest Coverage	0.75

Financial Efficiency

Return on equity (ROE) is -11.58% and return on invested capital (ROIC) is -1,176.15%.

Return on Equity (ROE)	-11.58%
Return on Assets (ROA)	2.49%
Return on Invested Capital (ROIC)	-1,176.15%
Return on Capital Employed (ROCE)	4.84%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	1.08M
Profits Per Employee	-46,272
Employee Count	499
Asset Turnover	0.73
Inventory Turnover	0.42

Taxes

In the past 12 months, FRA:AM6 has paid 23.25 million in taxes.

Income Tax	23.25M
Effective Tax Rate	14,293.72%

Stock Price Statistics

The stock price has increased by +30.11% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+30.11%
50-Day Moving Average	11.30
200-Day Moving Average	7.58
Relative Strength Index (RSI)	66.98
Average Volume (20 Days)	2

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.60

Income Statement

In the last 12 months, FRA:AM6 had revenue of EUR 540.16 million and -23.09 million in losses. Loss per share was -0.07.

Revenue	540.16M
Gross Profit	478.04M
Operating Income	29.38M
Pretax Income	162,675
Net Income	-23.09M
EBITDA	35.73M
EBIT	29.38M
Loss Per Share	-0.07

Balance Sheet

The company has 250.00 million in cash and 376.76 million in debt, with a net cash position of -126.76 million.

Cash & Cash Equivalents	250.00M
Total Debt	376.76M
Net Cash	-126.76M
Net Cash Per Share	n/a
Equity (Book Value)	233.57M
Book Value Per Share	0.75
Working Capital	373.34M

Cash Flow

In the last 12 months, operating cash flow was 28.23 million and capital expenditures -2.81 million, giving a free cash flow of 25.42 million.

Operating Cash Flow	28.23M
Capital Expenditures	-2.81M
Free Cash Flow	25.42M
FCF Per Share	n/a

Margins

Gross margin is 88.50%, with operating and profit margins of 5.44% and -4.27%.

Gross Margin	88.50%
Operating Margin	5.44%
Pretax Margin	0.03%
Profit Margin	-4.27%
EBITDA Margin	6.61%
EBIT Margin	5.44%
FCF Margin	4.71%

Dividends & Yields

FRA:AM6 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.31%
Shareholder Yield	-1.31%
Earnings Yield	-0.60%
FCF Yield	0.67%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:AM6 has an Altman Z-Score of -0.52 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.52
Piotroski F-Score	4